BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 09, 2015
 |  BC Week In Review  |  Clinical News  |  Regulatory

Iluvien fluocinolone acetonide intravitreal implant regulatory update

Finland and Luxembourg approved Iluvien fluocinolone acetonide intravitreal implant from Alimera to treat vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. The injectable...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >